GSE193838 catechin 0 v 5 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE193838_catechin_0_v_5_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE193838_catechin_0_v_5_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE193838_catechin_0_v_5_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE193838_catechin_0_v_5_human_up.

Results found

Linked to

 

Label

Description

 

Gene

MT-CO2 pseudogene 12

Gene

FSHD region gene 1 family member C, pseudogene

Gene

uncharacterized LOC339260

Gene

ribonuclease P subunit p21

Gene

MIR193b-365a host gene

Gene

CNN3 divergent transcript

Gene

MT-CO1 pseudogene 12

Gene

FOXF1 adjacent non-coding developmental regulatory RNA

Gene

BOLA3 divergent transcript

Gene

STAG3 cohesin complex component like 3 (pseudogene)

  • Gene

    MT-CO2 pseudogene 12


  • Gene

    FSHD region gene 1 family member C, pseudogene


  • Gene

    uncharacterized LOC339260


  • Gene

    ribonuclease P subunit p21


  • Gene

    MIR193b-365a host gene


  • Gene

    CNN3 divergent transcript


  • Gene

    MT-CO1 pseudogene 12


  • Gene

    FOXF1 adjacent non-coding developmental regulatory RNA


  • Gene

    BOLA3 divergent transcript


  • Gene

    STAG3 cohesin complex component like 3 (pseudogene)

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.